Kates M, Mansour AM, Lamm DL, et al. Phase 1/2 trial results of a large surface area microparticle docetaxel for the treatment of high-risk nonmuscle-invasive bladder cancer. J Urol. 2022 Oct;208(4):821-829. doi:10.1097/JU.0000000000002778
Local injection of docetaxel shows p... - Advanced Prostate...
Local injection of docetaxel shows promise for bladder cancer. Maybe it could be used for PCa where systematic therapy was not tolerated.
![Graham49 profile image](https://images.hu-production.be/avatars/ff790ac20a6f41c189e853c7f7646754_small@2x_100x100.jpg)
Written by
![Graham49 profile image](https://images.hu-production.be/avatars/ff790ac20a6f41c189e853c7f7646754_small@2x_100x100.jpg)
Graham49
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Interesting idea.
But only to supplement systemic therapy
By the time you get to docetaxel, you really don't know where the cancer is, even after a scan that will only find larger tumors.